Abstract
Among several mechanisms underlying the well-known trophic and protective effects of 17β-estradiol (E2) in the brain, we recently reported that E2 induces the up-regulation of two anti-apoptotic and neuroprotectant proteins: huntingtin (HTT) and neuroglobin (NGB). Here, we investigate the role of this up-regulation. The obtained results indicate that E2 promotes NGB-HTT association, induces the localization of the complex at the mitochondria, and protects SK-N-BE neuroblastoma cells and murine striatal cells, which express wild-type HTT (i.e., polyQ7), against H2O2-induced apoptosis. All E2 effects were completely abolished in HTT-knocked out SK-N-BE cells and in striatal neurons expressing the mutated form of HTT (mHTT; i.e., polyQ111) typical of Huntington’s disease (HD). As a whole, these data provide a new function of wild-type HTT which drives E2-induced NGB in mitochondria modulating NGB anti-apoptotic activity. This new function is lost by HTT polyQ pathological expansion. These data evidence the existence of a novel E2/HTT/NGB neuroprotective axis that may play a relevant role in the development of HD therapeutics.
Similar content being viewed by others
Abbreviations
- BSA:
-
Bovine serum albumin
- DMEM:
-
Dulbecco’s modified Eagle medium
- E2:
-
17β-Estradiol
- ER:
-
Estrogen receptor
- ERα:
-
Estrogen receptor α
- ERβ:
-
Estrogen receptor β
- HD:
-
Huntington’s disease
- HTT:
-
Wild-type huntingtin
- mHTT:
-
HTT mutant
- NGB:
-
Neuroglobin
- polyQ:
-
Polyglutamine
- RNS:
-
Reactive nitrogen species
- ROS:
-
Reactive oxygen species
- scRNA:
-
Scramble RNA
- shHTT:
-
Short hairpin RNA for HTT
References
Cattaneo E, Rigamonti D, Goffredo D, Zuccato C, Squitieri F, Sipione S (2001) Loss of normal huntingtin function: new developments in Huntington’s disease research. Trend Neurosci 24:182–188
Takano H, Gusella JF (2002) The predominantly HEAT-like motif structure of huntingtin and its association and coincident nuclear entry with dorsal, an NF-kB/Rel/dorsal family transcription factor. BMC Neurosci 3:15
Palidwor GA, Shcherbinin S, Huska MR, Rasko T, Stelzl U, Arumughan A et al (2009) Detection of alpha-rod protein repeats using a neural network and application to huntingtin. PLoS Comput Biol 5:e1000304
Ochaba J, Lukacsovich T, Csikos G, Zheng S, Margulis J, Salazar L et al (2014) Potential function for the Huntingtin protein as a scaffold for selective autophagy. Proc Natl Acad Sci U S A 111:16889–16894
Rui YN, Xu Z, Patel B, Chen Z, Chen D, Tito A et al (2015) Huntingtin functions as a scaffold for selective macroautophagy. Nat Cell Biol 17:262–275
Xia J, Lee DH, Taylor J, Vandelft M, Truant R (2003) Huntingtin contains a highly conserved nuclear export signal. Human Mol Genet 12:1393–1403
Li W, Serpell LC, Carter WJ, Rubinsztein DC, Huntington JA (2006) Expression and characterization of full-length huntingtin, an elongated HEAT repeat protein. J Biol Chem 281:15916–15922
Zuccato C, Valenza M, Cattaneo E (2010) Molecular mechanisms and potential therapeutic targets in Huntington’s disease. Physiol Rev 90:905–981
Saudou F, Humbert S (2016) The biology of huntingtin. Neuron 89:910–926
The Huntington’s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72:971–983
Ratovitski T, Chighladze E, Arbez N, Boronina T, Herbrich S, Cole RN et al (2012) Huntingtin protein interactions altered by polyglutamine expansion as determined by quantitative proteomic analysis. Cell Cycle 11:2006–2021
Cattaneo E, Zuccato C, Tartari M (2005) Normal huntingtin function: an alternative approach to Huntington’s disease. Nature Rev Neurosci 6:919–930
Borrell-Pagès M, Zala D, Humbert S, Saudou S (2006) Huntington’s disease: from huntingtin function and dysfunction to therapeutic strategies. Cellular and Molecular Life Sci 63:2642–2660
Clabough EB (2013) Huntington’s disease: the past, present, and future search for disease modifiers. Yale J Biol Med 86:217–233
Dragatsis I, Levine M, Zeitlin S (2000) Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice. Nat Genet 26:300–306
Amantea D, Russo R, Bagetta G, Corasaniti MT (2005) From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens. Pharmacol Res 52:119–132
Barha CK, Galea LA (2010) Influence of different estrogens on neuroplasticity and cognition in the hippocampus. Biochim Biophys Acta 1800:1056–1067
Gillies GE, McArthur S (2010) Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol Rev 62:155–198
Fiocchetti M, Ascenzi P, Marino M (2012) Neuroprotective effects of 17β-estradiol rely on estrogen receptor membrane initiated signals. Front Physiol 3:e73
Srivastava DP, Woolfrey KM, Penzes P (2013) Insights into rapid modulation of neuroplasticity by brain estrogens. Pharmacol Rev 65:1318–1350
McEwen BS (2014) Sex, stress and the brain: interactive actions of hormones on the developing and adult brain. Climacteric 17:18–25
Arevalo MA, Azcoitia I, Garcia-Segura LM (2015) The neuroprotective actions of oestradiol and oestrogen receptors. Nature Rev Neurosci 16:17–29
Bourque M, Morissette M, Di Paolo T (2015) Neuroprotection in Parkinsonian-treated mice via estrogen receptor α activation requires G protein-coupled estrogen receptor 1. Neuropharmacol 95:343–352
Chisholm NC, Sohrabji F (2016) Astrocytic response to cerebral ischemia is influenced by sex differences and impaired by aging. Neurobiol Dis 85:245–253
Fester L, Rune GM (2015) Sexual neurosteroids and synaptic plasticity in the hippocampus. Brain Res 1621:162–169
Kunimura Y, Iwata K, Iijima N, Kobayashi M, Ozawa H (2015) Effect of sex steroid hormones on the number of serotonergic neurons in rat dorsal raphe nucleus. Neurosci Lett 594:127–132
Li R, Cui J, Shen Y (2014) Brain sex matters: estrogen in cognition and Alzheimer’s disease. Mol Cell Endocrinol 389:13–21
Naderi V, Khaksari M, Abbasi R, Maghool F (2015) Estrogen provides neuroprotection against brain edema and blood brain barrier disruption through both estrogen receptors α and β following traumatic brain injury. Iran J Basic Med Sci 18:138–144
Pietranera L, Brocca ME, Roig P, Lima A, Garcia-Segura LM, De Nicola AF (2014) Estrogens are neuroprotective factors for hypertensive encephalopathy. J Steroid Biochem Mol Biol 146:15–25
Sarkar S, Jun S, Simpkins JW (2015) Estrogen amelioration of Aβ-induced defects in mitochondria is mediated by mitochondrial signaling pathway involving ERβ, AKAP and Drp1. Brain Res 1616:101–111
Scott N, Prigge M, Yizhar O, Kimchi T (2015) A sexually dimorphic hypothalamic circuit controls maternal care and oxytocin secretion. Nature 525:519–522
Sellers KJ, Erli F, Raval P, Watson IA, Chen D, Srivastava DP (2015) Rapid modulation of synaptogenesis and spinogenesis by 17β-estradiol in primary cortical neurons. Front Cell Neurosci 9:137
Uzum G, Bahçekapılı N, Baltaci AK, Mogulkoc R, Ziylan YZ (2015) Pre- and post-estrogen administration in global cerebral ischemia reduces blood-brain barrier breakdown in ovariectomized rats. Acta Physiol Hung 102:60–66
Xu P, Cao X, He Y, Zhu L, Yang Y, Saito K et al (2015) Estrogen receptor-α in medial amygdala neurons regulates body weight. J Clin Invest 125:2861–2876
De Marinis E, Marino M, Ascenzi P (2011) Neuroglobin, estrogens, and neuroprotection. IUBMB Life 63:140–145
Asl SZ, Khaksari M, Khachki AS, Shahrokhi N, Nourizade S (2013) Contribution of estrogen receptors alpha and beta in the brain response to traumatic brain injury. J Neurosurg 119:353–361
Morissette M, Le Saux M, D'Astous M, Jourdain S, Al Sweidi S, Morin N et al (2008) Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain. J Steroid Biochem Mol Biol 108:327–338
Greenberg DA, Jin K, Khan AA (2008) Neuroglobin: an endogenous neuroprotectant. Curr Opin Pharmacol 8:20–24
Yu Z, Fan X, Lo EH, Wang X (2009) Neuroprotective roles and mechanisms of neuroglobin. Neurol Res 31:122–127
De Marinis E, Ascenzi P, Pellegrini M, Galluzzo P, Bulzomi P, Arevalo MA et al (2010) 17β-estradiol-a new modulator of neuroglobin levels in neurons: role in neuroprotection against H2O2-induced toxicity. Neurosignals 18:223–235
Fiocchetti M, De Marinis E, Ascenzi P, Marino M (2013) Neuroglobin and neuronal cell survival. Biochim Biophys Acta 1834:1744–1749
Yu Z, Poppe JL, Wang X (2013) Mitochondrial mechanisms of neuroglobin’s neuroprotection. Oxidative Med Cell Longev 2013:756989
De Marinis E, Fiocchetti M, Acconcia F, Ascenzi P, Marino M (2013) Neuroglobin upregulation induced by 17β-estradiol sequesters cytocrome c in the mitochondria preventing H2O2-induced apoptosis of neuroblastoma cells. Cell Death Dis 4:e508
Nuzzo MT, Fiocchetti M, Ascenzi P, Marino M (2014) Neuroglobin and estrogen receptors: a new pathway of cell survival and cell death balance. Immun Endo Metabol Agents Med Chem 14:91–99
Nuzzo MT, Fiocchetti M, Trezza V, Ascenzi P, Marino M (2016) Huntingtin up-regulation is necessary for 17-β-estradiol protective effects against oxidative stress injury in human neuroblastoma cell line. Neurosci Res 103:59–63
Luine VN (2014) Estradiol and cognitive function: past, present and future. Horm Behav 66:602–618
Murakami G, Hojo Y, Ogiue-Ikeda M, Mukai H, Chambon P, Nakajima K et al. (2014) Estrogen receptor KO mice study on rapid modulation of spines and long-term depression in the hippocampus. Brain Res
Yoest KE, Cummings JA, Becker JB (2014) Estradiol, dopamine and motivation. Cent Nerv Syst Agent Med Chem 14:83–89
Fusco FR, Anzilotti S, Giampà C, Dato C, Laurenti D, Leuti A et al (2012) Changes in the expression of extracellular regulated kinase (ERK 1/2) in the R6/2 mouse model of Huntington’s disease after phosphodiesterase IV inhibition. Neurobiol Dis 46:225–233
Trettel F, Rigamonti D, Hilditch-Maguire P, Wheeler VC, Sharp AH, Persichetti F et al (2000) Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum Mol Genet 9:2799–2809
Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57:369–384
Fiocchetti M, Nuzzo MT, Totta P, Acconcia F, Ascenzi P, Marino M (2014) Neuroglobin, a pro-survival player in estrogen receptor α-positive cancer cells. Cell Death Dis 5:e1449
Nguyen KQ, Rymar VV, Sadikot AF (2016) Impaired TrkB signaling underlies reduced BDNF-mediated trophic support of striatal neurons in the R6/2 mouse model of Huntington's disease. Front Cell Neurosci 10:37
Giampà C, Montagna E, Dato C, Melone MA, Bernardi G, Fusco FR (2013) Systemic delivery of recombinant brain derived neurotrophic factor (BDNF) in the R6/2 mouse model of Huntington's disease. PLoS One 8:e64037
Yu Z, Liu N, Wang Y, Li X, Wang X (2012) Identification of neuroglobin-interacting proteins using yeast two-hybrid screening. Neurosci 200:99–105
Schmidt-Kastner R, Haberkamp M, Schmitz C, Hankeln T, Burmester T (2006) Neuroglobin mRNA expression after transient global brain ischemia and prolonged hypoxia in cell culture. Brain Res 1103:173–180
Ye SQ, Zhou XY, Lai XJ, Zheng L, Chen XQ (2009) Silencing neuroglobin enhances neuronal vulnerability to oxidative injury by down-regulating 14-3-3gamma. Acta Pharmacol Sin 30:913–918
Fordel E, Thijs L, Martinet W, Schrijvers D, Moens L, Dewilde S (2007) Anoxia or oxygen and glucose deprivation in SH-SY5Y cells: a step closer to the unraveling of neuroglobin and cytoglobin functions. Gene 398:114–122
Hundahl C, Kelsen J, Kjaer K, Ronn LC, Weber RE, Geuens E et al (2006) Does neuroglobin protect neurons from ischemic insult? A quantitative investigation of neuroglobin expression following transient MCAo in spontaneously hypertensive rats. Brain Res 1085:19–27
Khan AA, Wang Y, Sun Y, Mao XO, Xie L, Miles E et al (2006) Neuroglobin-overexpressing transgenic mice are resistant to cerebral and myocardial ischemia. Proc Natl Acad Sci U S A 103:17944–17948
Cai B, Lin Y, Xue XH, Fang L, Wang N, Wu ZY (2010) TAT-mediated delivery of neuroglobin protects against focal cerebral ischemia in mice. Exp Neurol 227:224–231
Li RC, Guo SZ, Lee SK, Gozal D (2010) Neuroglobin protects neurons against oxidative stress in global ischemia. J Cereb Blood Flow Metab 30:1874–1882
Szymanski M, Wang R, Fallin MD, Bassett SS, Avramopoulos D (2010) Neuroglobin and Alzheimer’s dementia: genetic association and gene expression changes. Neurobiol Aging 31:1835–1842
Khan AA, Mao XO, Banwait S, Jin K, Greenberg DA (2007) Neuroglobin attenuates beta-amyloid neurotoxicity in vitro and transgenic Alzheimer phenotype in vivo. Proc Natl Acad Sci U S A 104:19114–19119
Fordel E, Thijs L, Martinet W, Lenjou M, Laufs T, Van Bockstaele D et al (2006) Neuroglobin and cytoglobin overexpression protects human SH-SY5Y neuroblastoma cells against oxidative stress-induced cell death. Neurosci Lett 410:146–151
Raychaudhuri S, Skommer J, Henty K, Birch N, Brittain T (2010) Neuroglobin protects nerve cells from apoptosis by inhibiting the intrinsic pathway of cell death. Apoptosis 15:401–411
Fiocchetti M, Cipolletti M, Leone S, Naldini A, Carraro F, Giordano D et al (2016) Neuroglobin in breast cancer cells: effect of hypoxia and oxidative stress on protein level, localization, and anti-apoptotic function. PLoS One 11:e0154959
Nuzzo MT, Marino M (2016) Estrogen/Huntingtin: a novel pathway involved in neuroprotection. Neural Regen Res 11:402–403
Colin E, Régulier E, Perrin V, Dürr A, Brice A, Aebischer P et al (2005) Akt is altered in an animal model of Huntington’s disease and in patients. Eur J Neurosci 21:1478–1488
Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L et al (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington’s disease. Science 293:493–498
Cutrupi S, Ferrero G, Reineri S, Cordero F, De Bortoli M (2014) Genomic lens on neuroglobin transcription. IUBMB Life 66:46–51
Li SH, Cheng AL, Zhou H, Lam S, Rao M, Li H et al (2002) Interaction of Huntington disease protein with transcriptional activator Sp1. Mol Cell Biol 22:1277–1287
Boutell JM, Thomas P, Neal JW, Weston VJ, Duce J, Harper PS et al (1999) Aberrant interactions of transcriptional repressor proteins with the Huntington’s disease gene product, huntingtin. Hum Mol Genet 8:1647–1655
Harjes P, Wanker EE (2003) The hunt for huntingtin function: interaction partners tell many different stories. Trends Biochem Sci 28:425–433
Li SH, Li XJ (2004) Huntingtin–protein interactions and the pathogenesis of Huntington’s disease. Trends Genet 20:146–154
Subramaniam S, Sixt KM, Barrow R, Snyder SH (2009) Rhes, a striatal specific protein, mediates mutant huntingtin cytotoxicity. Science 324:1327–1330
Kaltenbach LS, Romero E, Becklin RR, Chettier R, Bell R, Phansalkar A et al (2007) Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS Genet 3:82
Bode FJ, Stephan M, Suhling H, Pabst R, Straub RH, Raber KA et al (2008) Sex differences in a transgenic rat model of Huntington’s disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males. Hum Mol Genet 17:2595–2609
Smith KM, Dahodwala N (2014) Sex differences in Parkinson’s disease and other movement disorders. Exp Neurol 259:44–56
Rigamonti D, Bauer JH, De-Fraja C, Conti L, Sipione S, Sciorati C et al (2000) Wild-type huntingtin protects from apoptosis upstream of caspase-3. J Neurosci 20:3705–3713
Acknowledgements
This work was supported by grants from Associazione Italiana Ricerca sul Cancro (AIRC, IG#15221) to M.M. and from Ministero dell’Istruzione, dell’Università e della Ricerca of Italy (PRIN 20109MXHMR_001) to P.A.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All experiments were approved by the Animal Ethics Committee of S. Lucia Foundation and were conducted in accordance with Italian legislation and European regulations (Guideline 86/609/EEC).
ᅟ
Conflict of Interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Supplementary Figure 1.
Western blot analyses of NGB and HTT levels in (A) SK-N-BE and (B) MCF-7 cells stimulated for 24 h with either vehicle or E2 (10−9 M). The amount of protein was normalized by comparison with vinculin levels. The data are typical Western blots of three independent experiments. (C) Confocal microscopy analysis (original magnification × 63) of NGB (red) and HTT (green) co-immuno-localization in MCF-7 cells treated with either vehicle or E2 (10–9 M) for 24 h. Yellow signals indicates NGB-HTT co-staining in a single Z-stack plane. Representative images from three different experiments are shown in up panel. The 8.2 IMARIS software was used to quantify NGB-HTT merged signals. Data are the mean ± SD of three different experiments. p < 0.001 was calculated with Student’s t test versus vehicle-treated samples (*). Scale bars =5 μm. (GIF 41 kb)
Rights and permissions
About this article
Cite this article
Nuzzo, M.T., Fiocchetti, M., Totta, P. et al. Huntingtin polyQ Mutation Impairs the 17β-Estradiol/Neuroglobin Pathway Devoted to Neuron Survival. Mol Neurobiol 54, 6634–6646 (2017). https://doi.org/10.1007/s12035-016-0337-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-016-0337-x